TARO-Bupropion XL (2021-09-13)
- Starting date:
- September 13, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76475
Last updated:
2021-09-21
Summary
-
Product:
TARO-Bupropion XL
Reason
Affected lot may contain black powder in the bottle from charcoal in the desiccant canister.
Depth of distribution
Wholesalers, Retailers.
Affected products
TARO-Bupropion XL
DIN, NPN, DIN-HIM
DIN 02475812
Dosage form
Tablet
Strength
Bupropion Hydrochloride 300 mg
Lot or serial number
AB88254
Companies
- Recalling Firm
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Sun Pharma Canada Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA